Recommended respiratory tests are not routinely performed for mucopolysaccharidosis patients
- PMID: 35141320
- PMCID: PMC8819247
- DOI: 10.1183/23120541.00567-2021
Recommended respiratory tests are not routinely performed for mucopolysaccharidosis patients
Abstract
Recommended respiratory tests used as major outcomes in clinical trials for MPS treatment cannot be routinely performed in everyday practice because neurocognitive impairment and motor skill difficulties affect compliance for most MPS patients https://bit.ly/3G4qp8U.
Copyright ©The authors 2022.
Conflict of interest statement
Conflict of interest: D. Lacombe reports personal fees from Sanofi-Genzyme outside the submitted work. The other authors all declare no conflict of interest.
Figures
References
-
- HAS. Protocole National de Diagnostic et de Soins (PNDS) Mucopolysaccharidoses n.d. Saint-Denis, Haute Authorité de Santé, 2016.
LinkOut - more resources
Full Text Sources